Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olgun Elicin

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Expert Opinion on Investigational Drugs|January 7, 2017
The latest prospects of investigational drugs for head and neck cancerOlgun Elicin, Mahmut Ozsahin
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2021
A link between seasonality and radiation-related toxicity: The big time or time will tell?: Response to Nowicka et alOlgun Elicin, Nikola Cihoric
Expert Opinion on Investigational Drugs|April 13, 2016
Current Role of Dacomitinib in Head and Neck CancerOlgun Elicin, Mahmut Ozsahin
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 11, 2018
Letter to the Editor on Nevens et alOlgun Elicin, Roland Giger
Cancers|April 5, 2020
Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their OutcomeOlgun Elicin, Roland Giger
Laryngo- Rhino- Otologie|January 5, 2018
Roland Giger, Olgun Elicin
Frontiers in Oncology|October 23, 2024
Editorial: Quality assurance and workflow optimization for the diagnosis and treatment of head and neck cancerOlgun Elicin, Sefik Hosal
Oral Oncology|July 28, 2023
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge - A systematic reviewMarc Müller, Jinji Li, Roland Giger, et al.
Expert Opinion on Investigational Drugs|February 15, 2019
Emerging patient-specific treatment modalities in head and neck cancer - a systematic reviewOlgun Elicin, Nikola Cihoric, Eugenia Vlaskou Badra, et al.
Head & Neck|October 12, 2018
Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservationLukas Anschuetz, Miranda Visini, Mohamed Shelan, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|January 7, 2017
The latest prospects of investigational drugs for head and neck cancerOlgun Elicin, Mahmut Ozsahin
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2021
A link between seasonality and radiation-related toxicity: The big time or time will tell?: Response to Nowicka et alOlgun Elicin, Nikola Cihoric
Expert Opinion on Investigational Drugs|April 13, 2016
Current Role of Dacomitinib in Head and Neck CancerOlgun Elicin, Mahmut Ozsahin
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 11, 2018
Letter to the Editor on Nevens et alOlgun Elicin, Roland Giger
Cancers|April 5, 2020
Comparison of Current Surgical and Non-Surgical Treatment Strategies for Early and Locally Advanced Stage Glottic Laryngeal Cancer and Their OutcomeOlgun Elicin, Roland Giger
Laryngo- Rhino- Otologie|January 5, 2018
Roland Giger, Olgun Elicin
Frontiers in Oncology|October 23, 2024
Editorial: Quality assurance and workflow optimization for the diagnosis and treatment of head and neck cancerOlgun Elicin, Sefik Hosal
Oral Oncology|July 28, 2023
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge - A systematic reviewMarc Müller, Jinji Li, Roland Giger, et al.
Expert Opinion on Investigational Drugs|February 15, 2019
Emerging patient-specific treatment modalities in head and neck cancer - a systematic reviewOlgun Elicin, Nikola Cihoric, Eugenia Vlaskou Badra, et al.
Head & Neck|October 12, 2018
Risk analysis for tracheostomy dependency in curatively treated laryngeal cancer with organ preservationLukas Anschuetz, Miranda Visini, Mohamed Shelan, et al.
Pageof 9